The gluttonous side of malignant melanoma: basic and clinical implications of macroautophagy
Identifieur interne : 001498 ( Main/Exploration ); précédent : 001497; suivant : 001499The gluttonous side of malignant melanoma: basic and clinical implications of macroautophagy
Auteurs : Agnieszka Checinska [Espagne] ; María S. Soengas [Espagne]Source :
- Pigment Cell & Melanoma Research [ 1755-1471 ] ; 2011-12.
English descriptors
- Teeft :
- Apoptosis, Arginine, Atg5, Atg7, Autolysosome, Autolysosomes, Autophagic, Autophagosome, Autophagosome formation, Autophagosomes, Autophagy, Autophagy factors, Autophagy programs, Beclin, Beclin1, Becn1, Biol, Braf, Caspase, Cell biol, Cell death, Checinska, Chloroquine, Curr, Cutaneous, Cytosolic, Deprivation, Dsrna, Electron microscopy, Ganesan, Hypoxia, Inducer, John wiley sons, John wiley sons autophagy, Kepp, Klionsky, Kroemer, Lazova, Lc3a, Lc3b, Leucine, Levine, Lysosomal, Lysosome, Macroautophagy, Malignant, Mammalian cells, Mediator, Melanocyte, Melanocytic, Melanoma, Melanoma cells, Melanoma progression, Melanoma specimens, Melanosome, Melanosomes, Metastatic, Mizushima, Modulators, Mtor, Nevus, Normal melanocytes, Pathway, Pawelek, Pigment cell melanoma, Pigmentation, Pleiotropic roles, Progression, Rab7, Rapamycin, Savaraj, Sirna, Soengas, Tissue specimens, Torc1, Tormo, Tumor cells, Vesicle, Wipi1, Xenograft, Zhang.
Abstract
True to their inherent aggressive behavior, melanomas keep impressing the melanoma community with their ability to bypass tumor suppressor mechanisms. Name a pathway with the potential to control cell survival and melanoma cells will likely have it potentiated by multiple genetic or epigenetic alterations. In the context of progression and chemoresistance, large efforts have been dedicated to the identification of protective mechanisms associated with or linked to apoptotic death programs. These studies have guided the design of targeted anticancer strategies. Still, the promise for pro‐apoptotic inducers as lead compounds for drug development has yet to come to fruition. It was then a question of time to identify alternative modulators of cell viability. An ideal candidate that is raising great expectations in the oncology field is autophagy, a catabolic process with multiple roles in cell homeostasis. Here we review the incipient literature on autophagy markers in melanocytic lesions. Intriguingly, histopathological studies are unveiling an intrinsic inter‐ and intratumor variability in the expression of autophagy modulators. Nonetheless, functional studies support a key role of autopaphagy programs in the response to a variety of stress factors. These include adaptive responses to nutrient deprivation, hypoxia and many anticancer agents, among other stimuli. Strategies are being also developed to mobilize the endocytic machinery and shift autolysosomes into death effectors. The opportunities that lie ahead in this field are exciting. Various authophagy mediators are potentially druggable. Moreover, animal models and the development of sophisticated screening methods offer a platform for multilevel academic–industrial collaborations. These efforts are expected to open avenues of research and, hopefully, lead to a more rational approach to melanoma treatment.
Url:
DOI: 10.1111/j.1755-148X.2011.00927.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000376
- to stream Istex, to step Curation: 000376
- to stream Istex, to step Checkpoint: 000474
- to stream Main, to step Merge: 001500
- to stream Main, to step Curation: 001498
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The gluttonous side of malignant melanoma: basic and clinical implications of macroautophagy</title>
<author><name sortKey="Checinska, Agnieszka" sort="Checinska, Agnieszka" uniqKey="Checinska A" first="Agnieszka" last="Checinska">Agnieszka Checinska</name>
</author>
<author><name sortKey="Soengas, Maria S" sort="Soengas, Maria S" uniqKey="Soengas M" first="María S." last="Soengas">María S. Soengas</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:E2AA3FD2487CF54BB6B51F2B4A58193B65061E24</idno>
<date when="2011" year="2011">2011</date>
<idno type="doi">10.1111/j.1755-148X.2011.00927.x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-H2BT9S04-L/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000376</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000376</idno>
<idno type="wicri:Area/Istex/Curation">000376</idno>
<idno type="wicri:Area/Istex/Checkpoint">000474</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000474</idno>
<idno type="wicri:doubleKey">1755-1471:2011:Checinska A:the:gluttonous:side</idno>
<idno type="wicri:Area/Main/Merge">001500</idno>
<idno type="wicri:Area/Main/Curation">001498</idno>
<idno type="wicri:Area/Main/Exploration">001498</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">The gluttonous side of malignant melanoma: basic and clinical implications of macroautophagy</title>
<author><name sortKey="Checinska, Agnieszka" sort="Checinska, Agnieszka" uniqKey="Checinska A" first="Agnieszka" last="Checinska">Agnieszka Checinska</name>
<affiliation wicri:level="3"><country xml:lang="fr">Espagne</country>
<wicri:regionArea>Melanoma Laboratory, Molecular Pathology Programme, Centro Nacional de Investigaciones Oncológicas (Spanish National Cancer Research Centre), Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Soengas, Maria S" sort="Soengas, Maria S" uniqKey="Soengas M" first="María S." last="Soengas">María S. Soengas</name>
<affiliation wicri:level="3"><country xml:lang="fr">Espagne</country>
<wicri:regionArea>Melanoma Laboratory, Molecular Pathology Programme, Centro Nacional de Investigaciones Oncológicas (Spanish National Cancer Research Centre), Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Pigment Cell & Melanoma Research</title>
<title level="j" type="alt">PIGMENT CELL MELANOMA RESEARCH</title>
<idno type="ISSN">1755-1471</idno>
<idno type="eISSN">1755-148X</idno>
<imprint><biblScope unit="vol">24</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="1116">1116</biblScope>
<biblScope unit="page" to="1132">1132</biblScope>
<biblScope unit="page-count">17</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2011-12">2011-12</date>
</imprint>
<idno type="ISSN">1755-1471</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1755-1471</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Apoptosis</term>
<term>Arginine</term>
<term>Atg5</term>
<term>Atg7</term>
<term>Autolysosome</term>
<term>Autolysosomes</term>
<term>Autophagic</term>
<term>Autophagosome</term>
<term>Autophagosome formation</term>
<term>Autophagosomes</term>
<term>Autophagy</term>
<term>Autophagy factors</term>
<term>Autophagy programs</term>
<term>Beclin</term>
<term>Beclin1</term>
<term>Becn1</term>
<term>Biol</term>
<term>Braf</term>
<term>Caspase</term>
<term>Cell biol</term>
<term>Cell death</term>
<term>Checinska</term>
<term>Chloroquine</term>
<term>Curr</term>
<term>Cutaneous</term>
<term>Cytosolic</term>
<term>Deprivation</term>
<term>Dsrna</term>
<term>Electron microscopy</term>
<term>Ganesan</term>
<term>Hypoxia</term>
<term>Inducer</term>
<term>John wiley sons</term>
<term>John wiley sons autophagy</term>
<term>Kepp</term>
<term>Klionsky</term>
<term>Kroemer</term>
<term>Lazova</term>
<term>Lc3a</term>
<term>Lc3b</term>
<term>Leucine</term>
<term>Levine</term>
<term>Lysosomal</term>
<term>Lysosome</term>
<term>Macroautophagy</term>
<term>Malignant</term>
<term>Mammalian cells</term>
<term>Mediator</term>
<term>Melanocyte</term>
<term>Melanocytic</term>
<term>Melanoma</term>
<term>Melanoma cells</term>
<term>Melanoma progression</term>
<term>Melanoma specimens</term>
<term>Melanosome</term>
<term>Melanosomes</term>
<term>Metastatic</term>
<term>Mizushima</term>
<term>Modulators</term>
<term>Mtor</term>
<term>Nevus</term>
<term>Normal melanocytes</term>
<term>Pathway</term>
<term>Pawelek</term>
<term>Pigment cell melanoma</term>
<term>Pigmentation</term>
<term>Pleiotropic roles</term>
<term>Progression</term>
<term>Rab7</term>
<term>Rapamycin</term>
<term>Savaraj</term>
<term>Sirna</term>
<term>Soengas</term>
<term>Tissue specimens</term>
<term>Torc1</term>
<term>Tormo</term>
<term>Tumor cells</term>
<term>Vesicle</term>
<term>Wipi1</term>
<term>Xenograft</term>
<term>Zhang</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">True to their inherent aggressive behavior, melanomas keep impressing the melanoma community with their ability to bypass tumor suppressor mechanisms. Name a pathway with the potential to control cell survival and melanoma cells will likely have it potentiated by multiple genetic or epigenetic alterations. In the context of progression and chemoresistance, large efforts have been dedicated to the identification of protective mechanisms associated with or linked to apoptotic death programs. These studies have guided the design of targeted anticancer strategies. Still, the promise for pro‐apoptotic inducers as lead compounds for drug development has yet to come to fruition. It was then a question of time to identify alternative modulators of cell viability. An ideal candidate that is raising great expectations in the oncology field is autophagy, a catabolic process with multiple roles in cell homeostasis. Here we review the incipient literature on autophagy markers in melanocytic lesions. Intriguingly, histopathological studies are unveiling an intrinsic inter‐ and intratumor variability in the expression of autophagy modulators. Nonetheless, functional studies support a key role of autopaphagy programs in the response to a variety of stress factors. These include adaptive responses to nutrient deprivation, hypoxia and many anticancer agents, among other stimuli. Strategies are being also developed to mobilize the endocytic machinery and shift autolysosomes into death effectors. The opportunities that lie ahead in this field are exciting. Various authophagy mediators are potentially druggable. Moreover, animal models and the development of sophisticated screening methods offer a platform for multilevel academic–industrial collaborations. These efforts are expected to open avenues of research and, hopefully, lead to a more rational approach to melanoma treatment.</div>
</front>
</TEI>
<affiliations><list><country><li>Espagne</li>
</country>
<region><li>Communauté de Madrid</li>
</region>
<settlement><li>Madrid</li>
</settlement>
</list>
<tree><country name="Espagne"><region name="Communauté de Madrid"><name sortKey="Checinska, Agnieszka" sort="Checinska, Agnieszka" uniqKey="Checinska A" first="Agnieszka" last="Checinska">Agnieszka Checinska</name>
</region>
<name sortKey="Soengas, Maria S" sort="Soengas, Maria S" uniqKey="Soengas M" first="María S." last="Soengas">María S. Soengas</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001498 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001498 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:E2AA3FD2487CF54BB6B51F2B4A58193B65061E24 |texte= The gluttonous side of malignant melanoma: basic and clinical implications of macroautophagy }}
This area was generated with Dilib version V0.6.33. |